We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+13.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.23B
AUM Growth
-$147M
Cap. Flow
-$391M
Cap. Flow %
-17.54%
Top 10 Hldgs %
45.21%
Holding
76
New
10
Increased
18
Reduced
33
Closed
12

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$34.9M
2
FOLD
Amicus Therapeutics
FOLD
+$31.3M
3
ACHN
Achillion Pharmaceuticals
ACHN
+$29M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$22.3M
5
MDT icon
Medtronic
MDT
+$21.5M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$64.7M
2
AMGN icon
Amgen
AMGN
+$44.1M
3
VTRS icon
Viatris
VTRS
+$34.4M
4
ABBV icon
AbbVie
ABBV
+$25.7M
5
CELG
Celgene Corp
CELG
+$24.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
26
DELISTED
Allergan Inc
AGN
$34.6M 1.55%
162,750
-110,900
-41% -$22.1M
GEVA
27
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$33.8M 1.51%
363,884
-238,461
-40% -$18.8M
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$31.7M 1.42%
1,120,379
-291,971
-21% -$8.12M
ACHN
29
DELISTED
Achillion Pharmaceuticals
ACHN
$29.1M 1.3%
+2,373,810
New +$29M
ICPT
30
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$28.4M 1.27%
181,847
+103,954
+133% +$19.2M
XLRN
31
DELISTED
Acceleron Pharma
XLRN
$27.8M 1.25%
713,995
-12,429
-2% -$433K
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$122B
$25.2M 1.13%
212,250
-117,647
-36% -$13.3M
RLYP
33
DELISTED
RELYPSA INC COM
RLYP
$25M 1.12%
811,330
+72,757
+10% +$1.73M
CLVS
34
DELISTED
Clovis Oncology, Inc.
CLVS
$23.7M 1.06%
+423,452
New +$22.3M
MDT icon
35
Medtronic
MDT
$108B
$22.4M 1%
+310,025
New +$21.5M
UTHR icon
36
United Therapeutics
UTHR
$26.4B
$21.1M 0.95%
162,880
-19,520
-11% -$2.52M
SGNT
37
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$20.9M 0.94%
833,861
-195,611
-19% -$5.74M
KPTI icon
38
Karyopharm Therapeutics
KPTI
$162M
$19.8M 0.89%
35,328
+2,772
+9% +$1.57M
ABT icon
39
Abbott
ABT
$184B
$18.3M 0.82%
+405,410
New +$17.7M
ISRG icon
40
Intuitive Surgical
ISRG
$129B
$18.2M 0.82%
309,744
-27,540
-8% -$1.53M
MNTA
41
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$17.6M 0.79%
1,459,603
-674,837
-32% -$7.71M
ALGN icon
42
Align Technology
ALGN
$12.1B
$17.3M 0.78%
309,031
+40,671
+15% +$2.15M
DXCM icon
43
DexCom
DXCM
$28.5B
$15.7M 0.71%
1,144,260
+39,196
+4% +$480K
AKRX
44
DELISTED
Akorn Inc
AKRX
$15.7M 0.71%
434,343
-150,300
-26% -$5.8M
NXTM
45
DELISTED
NxStage Medical Inc.
NXTM
$14.5M 0.65%
807,012
-74,720
-8% -$1.2M
HTWR
46
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$12.4M 0.56%
168,525
+29,676
+21% +$2.25M
HCA icon
47
HCA Healthcare
HCA
$86.2B
$10.6M 0.47%
+144,002
New +$10.1M
NVO
48
Novo Nordisk
NVO
$219B
$7.84M 0.35%
370,570
+76,200
+26% +$1.7M
AMPH icon
49
Amphastar Pharmaceuticals
AMPH
$840M
$7.67M 0.34%
660,232
– –
CBAY
50
DELISTED
Cymabay Therapeutics
CBAY
$6.96M 0.31%
708,585
– –
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Sectoral Asset Management held 76 positions worth $2.23B, down 6.2% from $2.38B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sectoral Asset Management withdrew a net $391M in Q4 2014, closing 12 positions and reducing 33 holdings. Its most notable exit was AbbVie, an estimated $25.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 89% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in Achillion Pharmaceuticals worth $29.1M.

  • Sectoral Asset Management's largest Q4 2014 buy was Achillion Pharmaceuticals: 2,373,810 shares worth $29.1M.
  • Sectoral Asset Management added most to Shire pic in Q4 2014, an estimated $34.9M increase.
  • Sectoral Asset Management's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $64.7M.
  • Sectoral Asset Management fully exited AbbVie in Q4 2014, selling an estimated $25.7M.
  • Sectoral Asset Management's ten largest holdings make up 45% of its $2.23B portfolio in Q4 2014.
  • Sectoral Asset Management opened 10 new positions and closed 12 in Q4 2014.
  • Sectoral Asset Management's portfolio value fell 6.2% quarter-over-quarter to $2.23B.

Based on Sectoral Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.